findmyKOL

Aaron Miller, MD

Enriched profile

Medical Director, Corinne Goldsmith Dickinson Center for Multiple Sclerosis; Professor of Neurology, Icahn School of Medicine at Mount Sinai · Icahn School of Medicine at Mount Sinai

ORCIDNone on fileNPI
Region🇺🇸 New York, NY · Northeast · United StatesSpecialtyNeurologyFocusMultiple Sclerosis
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationNone indexedOnline presenceverified 2026Payments2021–2025NIH funding2006–2022Why? →

Aaron Miller is Medical Director, Corinne Goldsmith Dickinson Center for Multiple Sclerosis; Professor of Neurology, Icahn School of Medicine at Mount Sinai at Icahn School of Medicine at Mount Sinai. ClinicalTrials.gov lists 6 registered studies with this person as an investigator.

Data verified 14 Aug 2026

Overview

Updated 1 Sept 2026

Aaron Miller, M.D., is Medical Director, Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Icahn School of Medicine at Mount Sinai / Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Mount Sinai Health System. The public record shows 76 publications with 13,237 citations (h-index 16), centered on Multiple Sclerosis. It also documents an investigator role on 6 registered clinical trials, industry payments reported by 16 companies, 2 NIH-funded awards (2006–2022).

  • Top research focus: Multiple Sclerosis
  • 6 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 16 companies

Generated from the cited public record · current as of 1 Sept 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Multiple Sclerosis4 trialsMultiple Sclerosis, Chronic Progressive1 trialStroke1 trialDehydration1 trialHeat Stroke1 trial

Research focus

OpenAlex concept fingerprint
Multiple Sclerosis

Drugs & molecules

across trials, industry payments and publications
Upliznageneric · InebilizumabClinical trialsIndustry payments33PublicationsSolirisgeneric · EculizumabClinical trialsIndustry payments4PublicationsBafiertamgeneric · Monomethyl fumarateClinical trialsIndustry payments2Publications

Works with

trial sponsors and companies reporting payments
Biogen, Inc.Clinical trialsIndustry payments38Horizon Therapeutics plcClinical trialsIndustry payments33Alexion Pharmaceuticals, Inc.Clinical trialsIndustry payments22

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
16h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
6clinical trials

Investigator role on registered studies.

View trials
16companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
2NIH grants · 2006–2022

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 1 Sept 2026

Listed as an investigator on 6 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 1 Sept 2026

16 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2021)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    33.8%
    Other immunostimulants17.6%
    Copaxone100%
    Part D<11 patients
    Interferon beta16.2%
    Rebif100%
    Part D<11 patients
  • Musculoskeletal

    31.1%
    gamma-Aminobutyric Acid-ergic Agonist31.1%
    Baclofen100%
    Part D<11 patients
  • Nervous system

    20.3%
    Potassium Channel Blocker20.3%
    Dalfampridine Er100%
    Part D<11 patients
1 more therapeutic area behind the reveal.Reveal →
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 1 Sept 2026

2 NIH research awards on record, funded 20062022 per NIH RePORTER. The latest:

Publications

None on file yet. We only list publications we can confidently match to this person. Why? →

Online presence

Updated 1 Sept 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • ResearchGate

    researchgate.net/profile/Aaron-Miller-21

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net
  • LinkedIn

    linkedin.com/in/miller-aaron-a81a6830

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com
  • ResearchGate

    researchgate.net/scientific-contributions/Aaron-Miller-60530161

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net

Mentions by others

where others cite or feature them
  • Other

    realtalkms.com/episode-134-covid-19-and-ms-updates-with-dr-aaron-miller

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →realtalkms.com
  • Other

    mountsinai.org/about/newsroom/2013/medscape-five-triggers-in-multiple-sclerosis-aaron-miller-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mountsinai.org
  • Other

    mountsinai.org/about/newsroom/2014/webmd-dr-aaron-miller-multiple-sclerosis-health-center

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mountsinai.org

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 1 Sept 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • M.D.

    New York University School of Medicine

    1968
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →en.wikipedia.org
  • B.A.

    Brandeis University

    1964
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org
  • Residency in Neurology

    Albert Einstein College of Medicine

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctor.webmd.com
  • provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com

Editorial & leadership roles

journal and society appointments
  • Chairman

    Clinical Advisory Committee, New York Chapter of the National Multiple Sclerosis Society

    2004
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org
  • First Editor

    Continuum (American Academy of Neurology's continuing education publication)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org
  • First Chairman

    Multiple Sclerosis Section, American Academy of Neurology

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org
2 more roles behind the reveal.Reveal →

Awards & honors

honors on the public record
2 more awards behind the reveal.Reveal →

Secondary affiliations

appointments beyond the home institution
  • Former Director

    Division of Neurology, and Director, Multiple Sclerosis Care Center, Maimonides Medical Center, Brooklyn, NY (23 years, prior to joining Mount Sinai)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org

Media & interviews

press, podcasts and appearances
  • Featured expert

    WebMD "Multiple Sclerosis Health Center" video

    2014
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mountsinai.org
  • Featured expert

    Medscape article "Five Triggers in Multiple Sclerosis"

    2013
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mountsinai.org
  • Guest

    RealTalk MS podcast - Episode 134: "COVID-19 and MS Updates with Dr. Aaron Miller"

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →realtalkms.com

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.